Howard G. Parsons

1.5k total citations
30 papers, 1.2k citations indexed

About

Howard G. Parsons is a scholar working on Rheumatology, Physiology and Nutrition and Dietetics. According to data from OpenAlex, Howard G. Parsons has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 7 papers in Physiology and 7 papers in Nutrition and Dietetics. Recurrent topics in Howard G. Parsons's work include Folate and B Vitamins Research (5 papers), Neonatal Respiratory Health Research (4 papers) and Child Nutrition and Feeding Issues (3 papers). Howard G. Parsons is often cited by papers focused on Folate and B Vitamins Research (5 papers), Neonatal Respiratory Health Research (4 papers) and Child Nutrition and Feeding Issues (3 papers). Howard G. Parsons collaborates with scholars based in Canada, United States and Sri Lanka. Howard G. Parsons's co-authors include Gordon H. Fick, R. B. Scott, Samuel A. Zamora, J. Decker Butzner, Harish Amin, Douglas McMillan, Humberto Jijon, Karen Madsen, M. Eric Hyndman and Braden Manns and has published in prestigious journals such as PEDIATRICS, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Howard G. Parsons

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard G. Parsons Canada 15 337 287 266 211 171 30 1.2k
Kaj Anker Jørgensen Denmark 23 307 0.9× 369 1.3× 146 0.5× 95 0.5× 209 1.2× 72 1.6k
Ali Akçay Türkiye 23 222 0.7× 331 1.2× 197 0.7× 77 0.4× 183 1.1× 63 1.6k
Maria Aparecida Dalboni Brazil 23 288 0.9× 219 0.8× 192 0.7× 85 0.4× 293 1.7× 90 1.7k
C. Conri France 19 125 0.4× 314 1.1× 190 0.7× 209 1.0× 198 1.2× 62 1.5k
Edgar Delvin Canada 25 382 1.1× 253 0.9× 157 0.6× 128 0.6× 288 1.7× 64 2.0k
Vladimı́r Teplan Czechia 22 256 0.8× 200 0.7× 212 0.8× 70 0.3× 138 0.8× 85 1.5k
Raffaele Iorio Italy 28 690 2.0× 484 1.7× 178 0.7× 152 0.7× 174 1.0× 125 2.4k
Franklin D. McDonald United States 23 286 0.8× 253 0.9× 234 0.9× 52 0.2× 192 1.1× 78 1.5k
William P. Baldus United States 22 434 1.3× 460 1.6× 214 0.8× 104 0.5× 123 0.7× 32 2.1k
Hieronymus A.M. Voorbij Netherlands 27 137 0.4× 379 1.3× 204 0.8× 79 0.4× 176 1.0× 62 2.0k

Countries citing papers authored by Howard G. Parsons

Since Specialization
Citations

This map shows the geographic impact of Howard G. Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard G. Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard G. Parsons more than expected).

Fields of papers citing papers by Howard G. Parsons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard G. Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard G. Parsons. The network helps show where Howard G. Parsons may publish in the future.

Co-authorship network of co-authors of Howard G. Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Howard G. Parsons. A scholar is included among the top collaborators of Howard G. Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard G. Parsons. Howard G. Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Howard G., M. A. George, & Sheila M. Innis. (2011). Growth Assessment in Clinical Practice: Whose Growth Curve?. Current Gastroenterology Reports. 13(3). 286–292. 7 indexed citations
2.
3.
Verma, Subodh, et al.. (2002). Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. American Journal of Physiology-Heart and Circulatory Physiology. 282(6). H2167–H2172. 97 indexed citations
4.
Barker, Collin, J. Decker Butzner, Richard C. Woodman, & Howard G. Parsons. (2001). Crohn-like Enteritis Presenting as Hypoglycemia in a Patient With Glycogen Storage Disease Type 1b, Treated With Granulocyte Colony-stimulating Factor and Splenectomy. Journal of Pediatric Gastroenterology and Nutrition. 32(2). 197–200. 4 indexed citations
5.
Manns, Braden, Eric Hyndman, Ellen Burgess, et al.. (2001). Oral vitamin B12 and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia. Kidney International. 59(3). 1103–1109. 35 indexed citations
6.
Hyndman, M. Eric, Peter J. Bridge, J. Wayne Warnica, Gordon H. Fick, & Howard G. Parsons. (2000). Effect of heterozygosity for the methionine synthase 2756 A→G mutation on the risk for recurrent cardiovascular events. The American Journal of Cardiology. 86(10). 1144–1146. 35 indexed citations
7.
Jijon, Humberto, et al.. (2000). Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 279(3). G641–G651. 115 indexed citations
8.
Parsons, Howard G., et al.. (2000). Anaerobic exercise increases fat-free mass but not extracellular water during prolonged, 6°-head-down bed rest. Pflügers Archiv - European Journal of Physiology. 441(S1). R73–R78. 3 indexed citations
9.
Manns, Braden, Ellen Burgess, M. Eric Hyndman, et al.. (1999). Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. American Journal of Kidney Diseases. 34(4). 669–677. 73 indexed citations
10.
Manns, Braden, Ellen Burgess, Howard G. Parsons, et al.. (1999). Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney International. 55(1). 315–320. 59 indexed citations
11.
Zamora, Samuel A., Harish Amin, Douglas McMillan, et al.. (1998). Plasma L-arginine concentration, oxygenation index, and systemic blood pressure in premature infants. Critical Care Medicine. 26(7). 1271–1276. 19 indexed citations
12.
13.
Lafrenière, René, et al.. (1997). Lovastatin Increases Surface Low Density Lipoprotein Receptor Expression by Retarding the Receptor Internalization Rate in Proliferating Lymphocytes. Biochemical and Biophysical Research Communications. 235(1). 117–122. 7 indexed citations
14.
Zamora, Samuel A., Harish Amin, Douglas McMillan, et al.. (1997). Plasma l -arginine concentrations in premature infants with necrotizing enterocolitis. The Journal of Pediatrics. 131(2). 226–232. 131 indexed citations
15.
16.
Parsons, Howard G., et al.. (1995). Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance. Metabolism. 44(1). 13–18. 13 indexed citations
17.
Parsons, Howard G.. (1994). Nutrient modulation of the immune response. Immunology Today. 15(12). 599–600. 12 indexed citations
18.
Parsons, Howard G.. (1990). Stable isotopes in the management and diagnosis of inborn errors of metabolism. Canadian Journal of Physiology and Pharmacology. 68(7). 950–954. 3 indexed citations
19.
Parsons, Howard G., G. Shillabeer, & Alfred Rademaker. (1984). Early onset of essential fatty acid deficiency in patents with cystic fibrosis receiving a semisynthetic diet. The Journal of Pediatrics. 105(6). 958–961. 8 indexed citations
20.
Parsons, Howard G.. (1982). Essays on Pediatric Nutrition. Canadian Medical Association Journal. 126(5). 516–517. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaj Anker Jørgensen Breakdown of academic impact, for papers by Ali Akçay Breakdown of academic impact, for papers by Maria Aparecida Dalboni Breakdown of academic impact, for papers by C. Conri Breakdown of academic impact, for papers by Edgar Delvin Breakdown of academic impact, for papers by Vladimı́r Teplan Breakdown of academic impact, for papers by Raffaele Iorio Breakdown of academic impact, for papers by Franklin D. McDonald Breakdown of academic impact, for papers by William P. Baldus Breakdown of academic impact, for papers by Hieronymus A.M. Voorbij
Rankless by CCL
2026